I know my time is limited. I have another question I want to get on the record before my time evaporates, as it does very quickly here.
The question is for the CMA. When a drug shortage is identified, and we're looking at an alternative drug, some have suggested that it should be a government body that does that. Wouldn't it make sense to have pharmacists and physicians look at what the alternatives should be? What role do you think physicians should have in that process?